Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.65 USD | -3.89% | +3.24% | -7.94% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
Financials (USD)
Sales 2024 * | 3.04M | Sales 2025 * | 12.25M | Capitalization | 451M |
---|---|---|---|---|---|
Net income 2024 * | -200M | Net income 2025 * | -222M | EV / Sales 2024 * | 93.2 x |
Net cash position 2024 * | 168M | Net cash position 2025 * | 170M | EV / Sales 2025 * | 22.9 x |
P/E ratio 2024 * |
-2.35
x | P/E ratio 2025 * |
-2.63
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 36.68% |
Latest transcript on IGM Biosciences, Inc.
1 day | -3.89% | ||
1 week | +3.24% | ||
Current month | -20.73% | ||
1 month | -12.17% | ||
3 months | -28.37% | ||
6 months | +70.38% | ||
Current year | -7.94% |
Managers | Title | Age | Since |
---|---|---|---|
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 03-01-31 |
Misbah Tahir
DFI | Director of Finance/CFO | 49 | 18-12-31 |
T. S. Harigopal
COO | Chief Operating Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 21-01-25 |
M. Wilsey
BRD | Director/Board Member | 71 | 19-01-30 |
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 03-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% | ||
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 7.65 | -3.89% | 546,460 |
24-04-24 | 7.96 | +3.38% | 693,446 |
24-04-23 | 7.7 | +14.07% | 413,520 |
24-04-22 | 6.75 | -6.25% | 238,720 |
24-04-19 | 7.2 | -2.83% | 219,365 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.94% | 469M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- IGMS Stock